Any mild inflammation and immune response can lead to hyperplasia of enterochromaffin cells, increased serotonin production and secretion and reduced SERT expression, as a result of which IBS clinical symptoms appear (Thijssen et al., 2016[65]). Here, SLC6A4 is linked to irritable bowel syndrome.